United States ex rel. Radcliffe v. Purdue Pharma L.P.

178 L. Ed. 2d 315, 131 S. Ct. 477, 562 U.S. 977, 2010 U.S. LEXIS 7874, 79 U.S.L.W. 3227, 31 I.E.R. Cas. (BNA) 480
CourtSupreme Court of the United States
DecidedOctober 12, 2010
DocketNo. 10-254
StatusPublished
Cited by1 cases

This text of 178 L. Ed. 2d 315 (United States ex rel. Radcliffe v. Purdue Pharma L.P.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. Radcliffe v. Purdue Pharma L.P., 178 L. Ed. 2d 315, 131 S. Ct. 477, 562 U.S. 977, 2010 U.S. LEXIS 7874, 79 U.S.L.W. 3227, 31 I.E.R. Cas. (BNA) 480 (U.S. 2010).

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Justice Kagan took no part in the consideration or decision of this petition.

Same case below, 600 F.3d 319.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
178 L. Ed. 2d 315, 131 S. Ct. 477, 562 U.S. 977, 2010 U.S. LEXIS 7874, 79 U.S.L.W. 3227, 31 I.E.R. Cas. (BNA) 480, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-radcliffe-v-purdue-pharma-lp-scotus-2010.